Organization | International Agency for Research on Cancer

International Agency for Research on Cancer Report issue

Foundation Phase 3 Phase 4

Founded: Lyon France (1965)

Organization Overview

First Clinical Trial

2009

NCT00923702

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Dr R. Sankaranarayanan | International Agency for Research on Cancer

Active Ingredients

Drugs in Phase 4 Trials (6)

clarithromycin (biaxin) (1 trial)

esomeprazole (nexium) (1 trial)

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)

metronidazole (flagyl) (2 trials)

procaine benzylpenicillin (novocaine) (1 trial)

tetracycline (tetrex) (2 trials)

Drugs in Phase 3 Trials (4)

attenuated live hepatitis A vaccine (1 trial)

bismuth (1 trial)

human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)

lansoprazole (prevacid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Gastritis (Phase 4)

Gastritis, Atrophic (Phase 4)

Stomach Neoplasms (Phase 4)

Uterine Cervical Neoplasms (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 10